Blog

CCRAN’s Early Age Onset Cancer Symposium

Early Age Onset Cancer/FaceBook

Nov 22, 2024, 10:19

CCRAN’s Early Age Onset Cancer Symposium

Pashtoon Kasi, Medical Director of GI Medical Oncology at City of Hope, reshared a post by CCRAN on LinkedIn, adding:

“The rise of early onset colorectal and other cancers is concerning.

Important to note the updates in management including immunotherapy. It is in this bucket of treatments where the long term durable control cures lie.

Also, remember universal germline and comprehensive genomic testing alongside ctDNA. Till we have more options, we will miss 100% of the chances we didn’t take for the subsets where we have actionable aberrations.”

Quoting CCRAN‘s post:

“WATCH EAOC24 LIVE!!

CCRAN’s Early Age Onset Cancer Symposium and access all event recordings after the event.

Click here to register now or through the link in our bio!
LIVE NOW: What’s New in the Management of Metastatic Cancer?

Moderator:

Dr. Joseph C. Del Paggio, Medical Oncologist, Thunder Bay Regional Health Sciences Centre
Dr. Christine Brezden-Masley, Medical Oncologist, and Medical Director, Cancer Program, Sinai Health
Dr. Ravi Ramjeesingh, Medical Oncologist & Assistant Professor, Nova Scotia Cancer Centre & Dalhousie University
Dr. Ronald Burkes, Professor of Medicine, University of Toronto, Medical Oncologist, Mount Sinai Hospital
Dr. Pashtoon M. Kasi, Director of GI Oncology, City of Hope, Orange County, Irvine, CA, USA
Dr. José Perea, Chief, Department of Surgery, Vithas Arturo Soria University Hospital
Dr. Helen MacKay, Medical Oncologist, Odette Cancer Center”

CCRAN's Early Age Onset Cancer Symposium

Dr. Pashtoon Kasi is the Medical Director of GI Medical Oncology at City of Hope, Orange County. Previously, Dr. Kasi served as an Associate Professor of Medicine in the Division of Hematology and Oncology at the University of Iowa, following positions as an Assistant Professor of Medicine and Oncology at both the University of Iowa and Mayo Clinic. He also served as the Director of Colon Cancer Research and Director of Precision Medicine Research for Liquid Biopsies at Weill Cornell Medicine.His research primarily focuses on “liquid biopsies,” particularly circulating tumor DNA (ctDNA) and circulating tumor cells (CTCs). Dr. Kasi is also recognized as an author and editor of several significant books, including “Research: What, Why, and How: A Treatise from Researchers to Researchers” and “Impact of Circulating Tumor DNA (ctDNA) in Patients with Gastrointestinal Malignancies.” His scholarly contributions extend to over 100 publications in esteemed peer-reviewed journals. He also received the Yvonne Award 2024 by OncoDaily in the “challenging the status quo” category.